Regencell Bioscience reaches a post-IPO peak adding to recent volatility

seekingalpha2021-08-26

Regencell Bioscience has nearly doubled in value, adding to the recent volatility shown by the Hong Kong-based company focused on traditional Chinese medicine (TCM). In mid-July, Regencell Bioscience(...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

jhno774
2021-08-26
jhno774
Nice
- jhno774:
  good
Pita2
2021-08-26
Pita2
Okay

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1177059583?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-08-26 10:49","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"1177059583","market":"us","top_or_hot":-1,"title":"Regencell Bioscience reaches a post-IPO peak adding to recent volatility","media":"seekingalpha","content":"<div>\n<p>Regencell Bioscience has nearly doubled in value, adding to the recent volatility shown by the Hong Kong-based company focused on traditional Chinese medicine (TCM).\nIn mid-July, Regencell Bioscience(...</p>\n\n<a href=\"https://seekingalpha.com/news/3734089-regencell-bioscience-reaches-a-post-ipo-peak-adding-to-recent-volatility\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regencell Bioscience reaches a post-IPO peak adding to recent volatility</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegencell Bioscience reaches a post-IPO peak adding to recent volatility\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-26 10:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3734089-regencell-bioscience-reaches-a-post-ipo-peak-adding-to-recent-volatility><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Regencell Bioscience has nearly doubled in value, adding to the recent volatility shown by the Hong Kong-based company focused on traditional Chinese medicine (TCM).\nIn mid-July, Regencell Bioscience(...</p>\n\n<a href=\"https://seekingalpha.com/news/3734089-regencell-bioscience-reaches-a-post-ipo-peak-adding-to-recent-volatility\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RGC","symbol_name":"脑再生科技","start_time":0,"source_url":"https://seekingalpha.com/news/3734089-regencell-bioscience-reaches-a-post-ipo-peak-adding-to-recent-volatility","article_id":"1177059583","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1177059583","pubTimestamp":1629946158,"columns":[],"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Regencell Bioscience has nearly doubled in value, adding to the recent volatility shown by the Hong ","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"RGC":"脑再生科技"},"translate_title":"Regencell Bioscience达到IPO后的高峰，加剧了最近的波动","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RGC":0.9},"content_text":"Regencell Bioscience has nearly doubled in value, adding to the recent volatility shown by the Hong Kong-based company focused on traditional Chinese medicine (TCM).\nIn mid-July, Regencell Bioscience(NASDAQ:RGC)went public, targeting to raise $21.9M in gross proceeds with the offering of 2.3M shares at $9.5 apiece. The stock has added ~178.0% since then, including ~204.1% recorded on August 20.\nHowever, highlighting the volatility, Regencell Bioscience (RGC) fell ~28.3% on Tuesday to post its biggest one-day loss since the public debut.\nCommenting on the IPO, Seeking Alpha contributor Donovan Jones argued that the companies focused on TCM enjoy a large market opportunity in China, which has the potential to grow at a double-digit rate due to the aging population and government backing.\nHowever, Jones, with a neutral view on Regencell Bioscience (RGC) pointed out that the company needs to differentiate its product offering as it takes on larger and more established players in the TCM market in China.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":810374620,"gmtCreate":1629948534560,"gmtModify":1676530181483,"author":{"id":"4091766705369530","authorId":"4091766705369530","name":"jhno774","avatar":"https://static.tigerbbs.com/1327aebace4dabb0bb59c972fe1f3a85","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4091766705369530","authorIdStr":"4091766705369530"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/810374620","repostId":1177059583,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5929102,"gmtCreate":1632103400674,"gmtModify":1634791710704,"authorId":4091766705369530,"author":{"id":4091766705369530,"idStr":"4091766705369530","authorId":4091766705369530,"name":"jhno774","avatar":"https://static.tigerbbs.com/1327aebace4dabb0bb59c972fe1f3a85","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":810374620,"type":1,"supId":0,"prevId":0,"content":"good","text":"good","html":"good"}],"langContent":"EN"},{"id":810373336,"gmtCreate":1629948071325,"gmtModify":1676530181101,"author":{"id":"4088111569952180","authorId":"4088111569952180","name":"Pita2","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"4088111569952180","authorIdStr":"4088111569952180"},"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/810373336","repostId":1177059583,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":29,"commentSize":2,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1177059583"}